Navigation Links
Bioscience for a Better Tomorrow – Exploring Recent Breakthroughs in Medical Technology on Advancements TV Series
Date:8/1/2019

Advancements with Ted Danson to focus on innovative medical technologies for personalized treatment. Check your local listings for more information.

Factor Bioscience Inc. (Factor) is pioneering nucleic-acid and cell-based technologies to advance the study and treatment of cancer and genetic and age-related diseases. This segment of Advancements will explore how Factor Bioscience is building the future of regenerative medicine by targeting and repairing the molecular origins of disease.

“Factor is excited to participate in Advancements and to share our discoveries in the burgeoning field of engineered cellular medicine,” explains Dr. Matt Angel, Co-Founder and CEO of Factor Bioscience. “These new technologies will allow us to fundamentally alter the way our bodies function, to effectively treat, and eventually eliminate currently untreatable diseases.”

The show will highlight Factor’s scientists, who developed the fastest, highest-efficiency method for reprogramming somatic cells to a pluripotent stem-cell state – a key invention now recognized by numerous patents. Viewers will see how this technology, which enables the production of patient-specific engineered cells for transplantation, has wide-ranging applications in cancer, neurodegenerative diseases, including Alzheimer’s disease and autoimmune diseases, along with multiple sclerosis and personalized regenerative medicine.

The technologies underlying this breakthrough also form the foundation of Factor’s protein-replacement and gene-editing platforms, allowing the company to target disease at the molecular level.

About Factor Bioscience:
Based in Cambridge, Massachusetts, Factor Bioscience is developing nucleic-acid and cell-based therapeutics using its patented mRNA, cell-reprogramming, and gene-editing technologies. Factor is focused on creating precision medical treatments, including engineered cellular medicines for people living with cancer and serious genetic and age-related diseases.

For more information, visit: http://www.factorbio.com.

About Advancements and DMG Productions:
The Advancements series is an information-based educational show targeting recent advances across a number of industries and economies. Featuring state-of-the-art solutions and important issues facing today’s consumers and business professionals, Advancements focuses on cutting-edge developments, and brings this information to the public with the vision to enlighten about how technology and innovation continue to transform our world.

Backed by experts in various fields, DMG Productions is dedicated to education and advancement, and to consistently producing commercial-free, educational programming on which both viewers and networks depend.

For more information, please visit http://www.AdvancementsTV.com or call Richard Lubin at 866-496-4065.

Read the full story at https://www.prweb.com/releases/bioscience_for_a_better_tomorrow_exploring_recent_breakthroughs_in_medical_technology_on_advancements_tv_series/prweb16471468.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. Meredith James, HT, PMP, Joins Flagship Biosciences as Vice President of Operations
2. LiquiTech and Spartan Bioscience Partner to Bring Innovative, Real-time Legionella Detection to Health Care Sector
3. Landsec and Spartan Bioscience Trial the World’s First On-Site Legionella DNA Test in the UK
4. Indivumed Partners with Flagship Biosciences to Provide Global Tissue-Based Diagnostics Services
5. SeqOnce Biosciences Launches RhinoSeq™ Rapid DNA Library Preparation Kit
6. StressMarq Biosciences Inc. PCT Patent Application for a Novel Antibody Therapeutic Candidate to Combat Parkinson’s Disease is Published
7. Fluxion Biosciences Receives National Cancer Institute Grant for Development of ERASE-Seq Liquid Biopsy Technology
8. ACEA Biosciences Joins Cell Manufacturing Research Initiative to Further Advance Cell Therapy Discovery
9. Tosoh Bioscience LLC invests in Semba Biosciences
10. ACEA Biosciences Launches xCELLigence® RTCA Software Pro to Further Enhance Immuno-Oncology Experimental Design and Analysis
11. ACEA Biosciences Releases New Version of NovoExpress® Flow Cytometry Software.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/11/2020)... ... March 11, 2020 , ... Polysense Technologies ... smart human body temperature infrared touch-free monitoring product family, a standalone thermal meter ... supporting flexible wireless uplink for cloud connectivity such as NB-IoT, Wi-Fi, LoRaWAN, and ...
(Date:3/5/2020)... ... March 05, 2020 , ... Patients in need of new teeth after ... Nickelice Brand of Dental Implants of Ocala. Same-day dental implants allow patients ... smile in just one day. This treatment utilizes advanced technology and Dr. Brand’s unique ...
(Date:3/4/2020)... ... March 04, 2020 , ... VGXI, Inc., a uniquely specialized ... nominated as a finalist in the category of Best Contract Manufacturing Organization for ... manufacturing of a DNA vaccine against the novel coronavirus, COVID-19, under a CEPI ...
Breaking Biology News(10 mins):
(Date:3/27/2020)... ... March 26, 2020 , ... iFirst Medical Technologies, Inc., a leader ... nasal swab test. , "COVID-19 poses a grave danger to public health here in ... iFirst are compelled to act. Broad-based testing and on-the-spot results promise to slow the ...
(Date:3/19/2020)... ... March 18, 2020 , ... Family counsellors, marriage/couples therapists, ... rapid insight into their perceptions of events. Imagine if a couple’s counsellor could ... they could measure the level of engagement of each individual in the therapeutic ...
(Date:3/12/2020)... ... 2020 , ... With the beginning of 2020, Park Systems, ... in Europe by inaugurating a new scientific facility for academic and industrial research ... Center Europe took place Tuesday, February 18, 2020, gathering customers, collaborators and business ...
(Date:3/10/2020)... ... March 10, 2020 , ... ... biopharmaceutical engineering firm, is pleased to announce the addition of Carson Dickey ... device qualification and validation in the biopharmaceutical cold chain. He provides design ...
Breaking Biology Technology: